Cargando…
Patient-derived glioblastoma stem cells respond differentially to targeted therapies
The dismal prognosis of glioblastoma is, at least in part, attributable to the difficulty in eradicating glioblastoma stem cells (GSCs). However, whether this difficulty is caused by the differential responses of GSCs to drugs remains to be determined. To address this, we isolated and characterized...
Autores principales: | Kanabur, Pratik, Guo, Sujuan, Rodgers, Cara M., Simonds, Gary R., Kelly, Deborah F., Gourdie, Robert G., Verbridge, Scott S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349922/ https://www.ncbi.nlm.nih.gov/pubmed/27863440 http://dx.doi.org/10.18632/oncotarget.13415 |
Ejemplares similares
-
Connexin 43 confers chemoresistance through activating PI3K
por: Pridham, Kevin J., et al.
Publicado: (2022) -
Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells
por: Tseng, Han-Ching, et al.
Publicado: (2015) -
Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest
por: Carén, Helena, et al.
Publicado: (2015) -
Symptomatic sacrococcygeal joint dislocation treated using closed manual reduction: A case report with 36-month follow-up and review of literature
por: Kanabur, Pratik, et al.
Publicado: (2017) -
Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival
por: Varghese, Robin T., et al.
Publicado: (2018)